Effect of Four Exercises on the Inter-recti Distance in Women (Traecho)

August 2, 2020 updated by: APOR B de Gasquet

Effect of Four Abdominal and Pelvic Exercises on the Inter-recti Distance in Women: an Observational Study

Diastasis rectus abdominis (DRA) is defined as an excessive separation between the two abdominal rectus muscles. It is generally quantified by the inter-recti distance. In postpartum women, the prevalence of diastasis is 60% six weeks after delivery.

The increase in the inter-recti distance has been associated with a decrease in strength and endurance of the trunk flexors and rotators (p < 0.05). Exercise during pregnancy has been shown to be helpful in the treatment of DRA. Nevertheless, there is still not strong evidence to establish what kind of exercise should be recommended during pregnancy and in postpartum.

The aim of this study is to compare the morphological and functional changes of the linea alba during four exercises.

Inter-recti distance, linea alba thickness and distortion index will be measured at rest, as well as during 4 exercises (draw in maneuver, crunch, pelvic floor muscle contraction and a "de Gasquet" exercise). Subgroup analysis will be performed to determine if the presence or absence of an abdominal diastasis has an influence on these outcomes.

A cross-sectional pilot study will be carried out. The main outcome measure will the inter-recti distance. Secondary outcomes will be the thickness of linea alba and distortion index.

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

54

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 78 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Adult parous women attending to several physiotherapy centers in Paris will be recruited

Description

Inclusion Criteria:

  • Adults
  • Parous
  • Women
  • Accepting to participe in the research

Exclusion Criteria:

  • Under curatorship
  • Persons deprived of their liberty by judicial or administrative decision
  • Having intellectual limitations that may limit the understanding of questionnaires or exercises
  • With limitations in understanding the French language
  • Pregnant women
  • History of pelvic / spine fractures
  • History of pelvic surgery
  • History of spinal surgery
  • History of abdominal surgery
  • History of lower limbs weakness, changes in osteotendinous reflexes or loss of sensitivity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inter-recti distance
Time Frame: During the exercise
The distance between the two medial borders of rectus abdominis muscles is measured using ultrasound
During the exercise

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Linea alba thickness
Time Frame: During the exercise
Linea alba thickness is measured using ultrasound
During the exercise
Distortion index of the linea alba
Time Frame: During the exercise
Average deviation of the linea alba from the shortest path between the recti measured using ultrasound
During the exercise

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Transversus abdominis thickness
Time Frame: During the exercise
Transversus abdominis thickness at 1cm lateral from the fascia transversalis measured using ultrasound
During the exercise
Current lumbopelvic pain intensity
Time Frame: During the assessement
Current lumbopelvic pain will be measured using a visual analog scale
During the assessement
Acute lumbopelvic pain severity
Time Frame: During the assessement
The participants will be asked about their lumbopelvic pain mean intensity in the last week using a visual analog scale
During the assessement
Chronic lumbopelvic pain severity
Time Frame: During the assessement
The participants will be asked about their lumbopelvic pain mean intensity in the last 6 months using a visual analog scale
During the assessement
Urinary symptoms
Time Frame: During the assessement
Urinary symptoms will be measured using the Urinary Symptom Profile questionnaires
During the assessement

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 25, 2020

Primary Completion (Anticipated)

February 1, 2021

Study Completion (Anticipated)

May 1, 2021

Study Registration Dates

First Submitted

July 9, 2020

First Submitted That Met QC Criteria

August 2, 2020

First Posted (Actual)

August 6, 2020

Study Record Updates

Last Update Posted (Actual)

August 6, 2020

Last Update Submitted That Met QC Criteria

August 2, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diastasis, Muscle

3
Subscribe